Logotipo de Valence
populares
Iniciar sesión
Loading data for CI — first visit, this takes a few seconds.

Añadir a la lista de seguimiento

Cigna Group

NYSE: CI · Precio en tiempo real · USD
280.92
+2.42 (0.87%)
Al cierre: Aug 18, 2026, 3:59 PM

Cigna Group (CI) Stock Price, Analysis & Data

0.87%
Precio de compra280.97
Capitalización de mercado73.91B
Ingresos (TTM)282.38B
Beneficio neto (TTM)6.42B
Beta0.32
EPS (TTM)24.17
Ratio PER (TTM)11.57
Adelante PE8.36
P/B (TTM)1.73
P/S (TTM)0.26
Earnings DateNov 5, 2026
Precio de venta281.2
Volumen163,593
Volumen medio (20D)1,700,838
Abierto279.61
Anterior Cerrar278.50
Rango del día279.16 - 282.75
Rango de 52 semanas239.51 - 315.47
analistan/a
Precio objetivon/a
Dividendos$6.24 (2.24%)
Fecha ex dividendo8 sept 2026

Acerca de CI

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug u...

[Leer más]
Industria Healthcare Plans
Sector Healthcare
IPO Fecha Mar 31, 1982
Empleados 65,669
Bolsa de Valores NYSE
Símbolo bursátil CI
Sitio web https://www.thecignagroup.com
Perfil completo de la empresa

Desempeño financiero

En 2025, los ingresos de Cigna fueron 273.85B, un aumento de 11.26% en comparación con 246.15B del año anterior. Las ganancias fueron 5.96B, un aumento de 73.47%.

Estados financieros

Sorpresa de resultados

Cigna ha publicado sus resultados trimestrales en Jul 30, 2026:
  • Ingresos de $71.4B falla las estimaciones por $0, con 6.65% Crecimiento interanual.
  • EPS de 7.78 supera las estimaciones en 0.18, con 8.06% Crecimiento interanual.

    • Próxima publicación de resultados

    Está previsto que Cigna Group publique sus resultados el Nov 5, 2026, antes de que se abra el mercado.
    Los analistas proyectan ingresos de ... Actualizar
    news image

    1 día hace · Zacks

    Is CVS Stock a Buy as Earnings Improve but Key Risks Remain Elevated?

    CVS Health enters the second half of 2026 with stronger earnings and Aetna gains, but medical costs and Caremark risks cloud the recovery.

    news image

    1 día hace · Zacks

    CVS' Q2 EPS Gains From Improved Health Care Benefits Profitability

    CVS Health's Q2 EPS jumps more than 40% as Health Care Benefits profitability improves, prompting a major boost to its 2026 AOI outlook.

    news image

    2 días hace · StockStory

    Q2 Earnings Outperformers: Cigna (NYSE:CI) And The Rest Of The Health Insurance Providers Stocks

    Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q2 health insurance providers earnings season.

    news image

    4 días hace · Zacks

    Can CVS Sustain Its 2026 Recovery After Raising Earnings Guidance?

    CVS Health is rebuilding momentum as Aetna drives stronger profits and higher 2026 guidance, but medical costs and PBM changes could test the recovery.

    news image

    5 días hace · Trefis

    The Signs Before UnitedHealth Stock Ran Were In Its Own Exit Plan

    Management had named the plan exits, the Medicare margin target and the repricing date before the run began.

    Página 1 de 2